2-[4-[[2-butyl-4-methyl-6-(phenylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid
C35H32N4O3 — CID 155519387
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[2-butyl-4-methyl-6-(phenylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid
2-[4-[[2-butyl-4-methyl-6-(phenylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid (PubChem CID 155519387) has the molecular formula C35H32N4O3 and a molecular weight of 556.67 g/mol. Its IUPAC name is 2-[4-[[2-butyl-4-methyl-6-(phenylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid.
Molecular Properties
| Compound Name | 2-[4-[[2-butyl-4-methyl-6-(phenylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid |
|---|---|
| PubChem CID | 155519387 |
| Molecular Formula | C35H32N4O3 |
| Molecular Weight | 556.67 g/mol |
| Exact Mass | 556.25 |
| IUPAC Name | 2-[4-[[2-butyl-4-methyl-6-(phenylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid |
| SMILES | CCCCc1nc2c(C)cc(C(=O)Nc3ccccc3)cc2n1Cc1cccc2c1ccn2-c1ccccc1C(=O)O |
| InChI | InChI=1S/C35H32N4O3/c1-3-4-17-32-37-33-23(2)20-25(34(40)36-26-12-6-5-7-13-26)21-31(33)39(32)22-24-11-10-16-29-27(24)18-19-38(29)30-15-9-8-14-28(30)35(41)42/h5-16,18-21H,3-4,17,22H2,1-2H3,(H,36,40)(H,41,42) |
| InChIKey | BFJBQDUYZNPMGQ-UHFFFAOYSA-N |
| XLogP | 7.63 |
| TPSA | 89.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 556.67 |
| LogP ≤ 5 | 7.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155519387 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.